Barclays analyst Gaurav Jain lowered the firm’s price target on Philip Morris (PM) to $145 from $155 and keeps an Overweight rating on the shares. At current currency rates, Philip Morris’ 2025 earnings will see 10% adverse impact, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PM:
- Philip Morris Announces Regular Quarterly Dividend
- FDA seeks White House approval to cut nicotine levels in cigarettes, NYT says
- Lone Pine takes new positions in Salesforce and Starbucks, exits Mastercard
- Lone Pine buys UnitedHealth, exits Workday in Q3
- FDA reauthorizes Swedish Match’s General snus as Modified Risk Tobacco Product